Essex Woodlands Health Ventures Has Trimmed Its Abiomed (ABMD) Holding by $84.53 Million as Valuation Rose; Rowan Companies Plc (RDC) Shares Declined While Brigade Capital Management LP Boosted Position by $552,000

February 15, 2018 - By Stephen Andrade

Don Morgan increased its stake in Rowan Companies Plc (RDC) by 20.44% based on its latest 2017Q3 regulatory filing with the SEC. Brigade Capital Management Lp bought 46,000 shares as the company’s stock declined 21.10% while stock markets rallied. The hedge fund run by Don Morgan held 271,000 shares of the oil & gas production company at the end of 2017Q3, valued at $3.48M, up from 225,000 at the end of the previous reported quarter. Brigade Capital Management Lp who had been investing in Rowan Companies Plc for a number of months, seems to be bullish on the $1.54 billion market cap company. The stock decreased 2.80% or $0.35 during the last trading session, reaching $12.16. About 1.07 million shares traded. Rowan Companies plc (NYSE:RDC) has declined 16.50% since February 15, 2017 and is downtrending. It has underperformed by 33.20% the S&P500.

Essex Woodlands Health Ventures Inc decreased its stake in Abiomed Inc (ABMD) by 34.7% based on its latest 2017Q3 regulatory filing with the SEC. Essex Woodlands Health Ventures Inc sold 503,182 shares as the company’s stock rose 15.32% with the market. The hedge fund held 946,818 shares of the health care company at the end of 2017Q3, valued at $159.63M, down from 1.45 million at the end of the previous reported quarter. Essex Woodlands Health Ventures Inc who had been investing in Abiomed Inc for a number of months, seems to be less bullish one the $11.54B market cap company. The stock increased 2.00% or $5.12 during the last trading session, reaching $260.59. About 196,491 shares traded. ABIOMED, Inc. (NASDAQ:ABMD) has risen 40.97% since February 15, 2017 and is uptrending. It has outperformed by 24.27% the S&P500.

Investors sentiment decreased to 0.7 in 2017 Q3. Its down 0.56, from 1.26 in 2017Q2. It turned negative, as 29 investors sold RDC shares while 87 reduced holdings. 29 funds opened positions while 52 raised stakes. 129.33 million shares or 3.45% less from 133.95 million shares in 2017Q2 were reported. Acadian Asset Management Lc has invested 0.01% in Rowan Companies plc (NYSE:RDC). Jpmorgan Chase & Communications holds 0.01% or 2.57M shares in its portfolio. Van Eck Assocs reported 0.1% of its portfolio in Rowan Companies plc (NYSE:RDC). State Board Of Administration Of Florida Retirement System has 111,161 shares. Fincl Bank Of Ny Mellon accumulated 2.25M shares or 0.01% of the stock. Parallax Volatility Advisers LP has 0% invested in Rowan Companies plc (NYSE:RDC). Grantham Mayo Van Otterloo & Ltd Liability stated it has 0.01% in Rowan Companies plc (NYSE:RDC). Royal Commercial Bank Of Canada has 51,424 shares for 0% of their portfolio. Voya Management Ltd Llc reported 0% of its portfolio in Rowan Companies plc (NYSE:RDC). Adams Asset Advsrs Limited Liability holds 94,948 shares or 0.17% of its portfolio. Aperio Grp Inc Ltd Liability stated it has 115,241 shares. 37,800 are owned by South Dakota Inv Council. Federated Inc Pa holds 162,099 shares. Moreover, Parametric Assoc Limited Liability Company has 0% invested in Rowan Companies plc (NYSE:RDC). York Capital Mgmt Glob Advisors Ltd Liability invested in 0.02% or 74,510 shares.

Among 33 analysts covering Rowan Companies Inc. (NYSE:RDC), 7 have Buy rating, 4 Sell and 22 Hold. Therefore 21% are positive. Rowan Companies Inc. had 96 analyst reports since July 22, 2015 according to SRatingsIntel. Piper Jaffray downgraded the shares of RDC in report on Wednesday, January 10 to “Hold” rating. On Wednesday, August 2 the stock rating was maintained by Piper Jaffray with “Buy”. Raymond James downgraded Rowan Companies plc (NYSE:RDC) on Tuesday, July 26 to “Market Perform” rating. The firm earned “Hold” rating on Wednesday, June 21 by BMO Capital Markets. The firm has “Buy” rating by Jefferies given on Wednesday, September 28. The company was upgraded on Thursday, January 28 by Morgan Stanley. As per Wednesday, October 18, the company rating was maintained by Cowen & Co. The company was upgraded on Monday, September 25 by UBS. The rating was maintained by Cowen & Co on Tuesday, September 5 with “Hold”. The stock has “Hold” rating by Jefferies on Thursday, January 4.

Brigade Capital Management Lp, which manages about $17.09B and $1.23B US Long portfolio, decreased its stake in Oclaro Inc (Put) (NASDAQ:OCLR) by 500,000 shares to 1.00 million shares, valued at $8.63M in 2017Q3, according to the filing. It also reduced its holding in Peabody Energy Corp New by 1.05 million shares in the quarter, leaving it with 328,537 shares, and cut its stake in California Res Corp.

Among 14 analysts covering Abiomed (NASDAQ:ABMD), 11 have Buy rating, 0 Sell and 3 Hold. Therefore 79% are positive. Abiomed had 32 analyst reports since August 4, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Thursday, February 1 by Jefferies. Raymond James upgraded the shares of ABMD in report on Friday, October 30 to “Outperform” rating. The company was maintained on Thursday, June 29 by Jefferies. BTIG Research maintained ABIOMED, Inc. (NASDAQ:ABMD) on Tuesday, August 4 with “Hold” rating. The stock of ABIOMED, Inc. (NASDAQ:ABMD) earned “Buy” rating by Sterne Agee CRT on Tuesday, August 18. As per Thursday, August 3, the company rating was maintained by Jefferies. The stock of ABIOMED, Inc. (NASDAQ:ABMD) has “Neutral” rating given on Monday, October 16 by BTIG Research. The firm has “Buy” rating by William Blair given on Thursday, June 8. The stock of ABIOMED, Inc. (NASDAQ:ABMD) has “Overweight” rating given on Thursday, April 6 by PiperJaffray. The firm has “Outperform” rating given on Wednesday, May 4 by Leerink Swann.

Since August 15, 2017, it had 0 insider buys, and 3 insider sales for $5.53 million activity. ROSE ERIC A MD sold $142,554 worth of ABIOMED, Inc. (NASDAQ:ABMD) on Wednesday, August 30. Greenfield Andrew J also sold $1.91 million worth of ABIOMED, Inc. (NASDAQ:ABMD) shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: